Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06827704 · ClinicalTrials.gov registry record · NA

Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women

A NA study of Physical Activity and Metabolic Syndrome, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
96
Enrollment target
2
Study locations

NCT06827704 is a NA study of Physical Activity and Metabolic Syndrome that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 96 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06827704, a NA study of Physical Activity and Metabolic Syndrome, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target
2
Study locations

Study Summary

This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.

Interventions

  • BEHAVIORAL Enhanced physical activity monitor which is Fitbit watch with mobile App
  • BEHAVIORAL Bollywood-style group dance
  • BEHAVIORAL PAMDance

Study Locations (2)

Illinois

  • Rush University College of Nursing - Chicago
  • Rush University College of Nursing - Sugar Grove

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2025-05-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT06827704

The ClinicalTrials.gov registry entry for NCT06827704 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (73% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Physical Activity appearing as the primary indexed condition, and to 3 interventions - of which Enhanced physical activity monitor which is Fitbit watch with mobile App is the first listed.

NCT06827704 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06827704 about?

NCT06827704 is a clinical study titled "Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women". This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.

What is the current status of trial NCT06827704?

This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2025-05-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06827704 study?

This clinical trial studies the following conditions: Physical Activity, Metabolic Syndrome, Breast Cancer Prevention.

What interventions are being tested in trial NCT06827704?

The interventions under investigation include: Enhanced physical activity monitor which is Fitbit watch with mobile App (BEHAVIORAL), Bollywood-style group dance (BEHAVIORAL), PAMDance (BEHAVIORAL).

Who is sponsoring clinical trial NCT06827704?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06827704 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.